Login to Your Account



Medgenics Lays More Runway for Biopump with $30M Raise

By Nuala Moran
Staff Writer

Wednesday, February 13, 2013
Medgenics Inc. reached the higher end of its ambitions in an issue of stocks and warrants, raising $30 million to provide funding for further clinical development of its Biopump protein drug implant technology.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription